ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast Cancer.

Jamunarani Veeraraghavan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.